Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune cell activation and inflammatory signaling pathways represent a broad category of biological processes rather than a single molecular target. These pathways, such as NF-κB, JAK-STAT, and MAPK, are critical for coordinating the body's response to pathogens, injury, and stress (Janeway's Immunobiology, 9th Ed). They involve the activation of various immune cells, including macrophages and lymphocytes, which subsequently release pro-inflammatory cytokines and chemokines (Nature Reviews Immunology, 2017). Chronic or aberrant activation of these signaling networks is a fundamental driver of autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease, as well as certain malignancies (Cell, 2010). Therapeutic intervention focuses on specific nodes within these pathways, such as cytokine receptors or intracellular kinases, to dampen the inflammatory response and restore immune homeostasis (Journal of Clinical Investigation, 2013).
Inhibition of pro-inflammatory cytokines or intracellular signaling enzymes to modulate immune cell function.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune cell activation and inflammatory signaling pathways.